Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anup Patel

Showing results (151-160 of 161) with videos related to

Pageof 17
Sort By:
European Urology|May 25, 2020
Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial "NIMBUS"Marc-Oliver Grimm, Antoine G van der Heijden, Marc Colombel, et al.
European Urology Oncology|June 13, 2019
Automated Bone Scan Index as an Imaging Biomarker to Predict Overall Survival in the Zometa European Study/SPCG11Mariana Reza, Manfred Wirth, Teuvo Tammela, et al.
Lancet (London, England)|November 1, 2011
Safety of medicine and the use of animals in researchKathy Archibald, Anthony D Baxter, Kelly BéruBé, et al.
The Journal of Craniofacial Surgery|January 4, 2021
Long-Term Neurocognitive Outcomes in Sagittal Synostosis: The Impact of ReoperationCarolyn Chuang, Tafadzwa L Chaunzwa, Robin Wu, et al.
Pediatrics|August 10, 2018
Neuroimaging of Early Life EpilepsyJason Coryell, William D Gaillard, Renée A Shellhaas, et al.
European Urology Open Science|October 12, 2023
Quality of Life in Patients with High-grade Non-muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS TrialChristine G J I van Straten, Christien Caris, Marc-Oliver Grimm, et al.
The Lancet. Neurology|January 3, 2016
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trialOrrin Devinsky, Eric Marsh, Daniel Friedman, et al.
Epilepsy & Behavior : E&B|June 11, 2019
Immediate outcomes in early life epilepsy: A contemporary accountAnne T Berg, Courtney Wusthoff, Renée A Shellhaas, et al.
European Urology|October 3, 2017
Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival ResultsRobert J Motzer, Alain Ravaud, Jean-Jacques Patard, et al.
The New England Journal of Medicine|October 11, 2016
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after NephrectomyAlain Ravaud, Robert J Motzer, Hardev S Pandha, et al.
Pageof 17

Showing results (151-160 of 161) with videos related to

Sort By:
Pageof 17
European Urology|May 25, 2020
Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial "NIMBUS"Marc-Oliver Grimm, Antoine G van der Heijden, Marc Colombel, et al.
European Urology Oncology|June 13, 2019
Automated Bone Scan Index as an Imaging Biomarker to Predict Overall Survival in the Zometa European Study/SPCG11Mariana Reza, Manfred Wirth, Teuvo Tammela, et al.
Lancet (London, England)|November 1, 2011
Safety of medicine and the use of animals in researchKathy Archibald, Anthony D Baxter, Kelly BéruBé, et al.
The Journal of Craniofacial Surgery|January 4, 2021
Long-Term Neurocognitive Outcomes in Sagittal Synostosis: The Impact of ReoperationCarolyn Chuang, Tafadzwa L Chaunzwa, Robin Wu, et al.
Pediatrics|August 10, 2018
Neuroimaging of Early Life EpilepsyJason Coryell, William D Gaillard, Renée A Shellhaas, et al.
European Urology Open Science|October 12, 2023
Quality of Life in Patients with High-grade Non-muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS TrialChristine G J I van Straten, Christien Caris, Marc-Oliver Grimm, et al.
The Lancet. Neurology|January 3, 2016
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trialOrrin Devinsky, Eric Marsh, Daniel Friedman, et al.
Epilepsy & Behavior : E&B|June 11, 2019
Immediate outcomes in early life epilepsy: A contemporary accountAnne T Berg, Courtney Wusthoff, Renée A Shellhaas, et al.
European Urology|October 3, 2017
Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival ResultsRobert J Motzer, Alain Ravaud, Jean-Jacques Patard, et al.
The New England Journal of Medicine|October 11, 2016
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after NephrectomyAlain Ravaud, Robert J Motzer, Hardev S Pandha, et al.
Pageof 17